Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.46 |
| ▸ | RET | P07949 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.43 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | ACP3 | P15309 | 1/20 | 0.41 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.41 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9165650 | 1.00 | IDO1 (0.46) | IDO1PDPK1RETHTR2ACA1 | |
| SCHEMBL21937667 | 1.00 | IDO1 (0.46) | IDO1PDPK1RETHTR2ACA1 | |
| Fluoride SCHEMBL29683041 | 0.98 | IDO1 (0.44) | IDO1PDPK1RETHTR2ACA1 | |
| SCHEMBL782544 | 0.88 | IDO1 (0.49) | IDO1RETHTR2A | |
| SCHEMBL8699708 | 0.88 | IDO1 (0.49) | IDO1RETHTR2A | |
| SCHEMBL29663637 | 0.88 | IDO1 (0.49) | IDO1RETHTR2A | |
| SCHEMBL9159890 | 0.88 | IDO1 (0.49) | IDO1RETHTR2A | |
| SCHEMBL9722657 | 0.86 | IDO1 (0.43) | IDO1RETHTR2A | |
| SCHEMBL22391437 | 0.79 | IDO1 (0.50) | IDO1PDPK1RETHTR2ACA1 | |
| SCHEMBL1567129 | 0.79 | HTR1A (0.47) | IDO1PDPK1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 425 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116626388-B | Inductance type sensor conditioning circuit based on LC resonance circuit | 上海交通大学 | 2026-05-12 | — | — | CN | claimed |
| CN-114509729-B | Efficient grid-free angle estimation method for bistatic MIMO radar under planar array | 南京邮电大学 | 2025-04-25 | — | — | CN | claimed |
| CN-118917550-A | Urban flood toughness evaluation modeling method based on low-carbon sustainable index coupling | 云南大学 | 2024-11-08 | — | — | CN | claimed |
| CN-118059279-A | Apparatus and method for reducing malodor on surfaces | 宝洁公司 | 2024-05-24 | — | — | CN | claimed |
| CN-111253397-B | MNK inhibitors | 上海迪诺医药科技有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-116283657-A | Indenone derivative and synthetic method and application thereof | 贵州大学 | 2023-06-23 | — | — | CN | claimed |
| CN-115021570-A | Circuit modeling method and output current control method of double-active-bridge micro inverter | 上海交通大学 | 2022-09-06 | — | — | CN | claimed |
| CN-114825446-A | Active damping stabilizing control method of double-active-bridge micro inverter | 上海交通大学 | 2022-07-29 | — | — | CN | claimed |
| CN-110536880-B | Process for producing indanecarbaldehyde | 三菱瓦斯化学株式会社 | 2022-07-05 | — | — | CN | claimed |
| US-20200140360-A1 | METHOD FOR PRODUCING INDANCARBALDEHYDE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-05-07 | — | — | US | claimed |
| EP-1252889-A1 | REMEDIES OR PREVENTIVES FOR PULMONARY INSUFFICIENCY CONTAINING DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVES | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2002-10-30 | — | — | EP | claimed |
| US-20020068841-A1 | Alkyl aromatic aldehydes | EXXONMOBIL CHEMICAL PATENTS INC. | 2002-06-06 | — | — | US | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-0856515-B1 | Method of making acetals | MILLIKEN & CO (US) | 2001-12-05 | — | — | EP | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| EP-0856515-A1 | Method of making acetals | MILLIKEN RESEARCH CORPORATION (US) | 1998-08-05 | — | — | EP | claimed |
| US-5731474-A | Method of making acetals | MILLIKEN RESEARCH CORPORATION (US) | 1998-03-24 | — | — | US | claimed |
| US-4727060-A | HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1988-02-23 | — | — | US | claimed |
| EP-0184550-A2 | 5-Amino-4-hydroxy valeryl amide derivatives | CIBA-GEIGY AG (CH) | 1986-06-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200140360-A1 | METHOD FOR PRODUCING INDANCARBALDEHYDE | INMT, IDO2, IDO1 | IDO1 3/4885PDPK1 4000/4885RET 2585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.